• 제목/요약/키워드: Malignant course

검색결과 134건 처리시간 0.022초

방광에 발생한 원발성 소세포암종의 세포학적 소견 -1 예 보고- (Cytologic Findings of Primary Small Cell Carcinoma of the Urinary Bladder - A case report -)

  • 권미선;안긍환;정진행;이승숙;고재수
    • 대한세포병리학회지
    • /
    • 제12권2호
    • /
    • pp.121-125
    • /
    • 2001
  • Primary small cell carcinoma of the urinary bladder is a rare malignant tumor. A more rapidly fatal course may be seen in advanced stages of small cell carcinoma as compared to similar stages of urothelial carcinoma. It is very important to recognize this distinct form of bladder cancer by urinary cytology The differential diagnosis of small cell carcinoma of the urinary bladder includes metastatic small cell carcinoma, urothelial carcinoma, and primary or secondary malignant lymphoma. This article highlights the urinary cytologic diagnosis of a case of primary small cell carcinoma. A 59-year-old male presented with gross hematuria for five months. Urinary cytology showed high cellularity consisting of tiny monotonous tumor cells in the necrotic background. The tumor cells occurred predominantly singly, but a few in clusters. The cytoplasm was so scanty that only a very narrow rim of it was seen. The nuclei were oval or round and had finely stippled chromatin. Rarely, the nuclei contain visible nucleoli. Frequently cell molding was noted in clusters. Many single cells demonstrated nuclear pyknosis or karyorrhexis. The histologic findings of transurethral resection and partial cystectomy specimen were those of small cell carcinoma. Cytologic distinction may be very difficult but careful attention to clinical features and cellualr details can classify these neoplasms correctly.

  • PDF

림프절의 전이성 소세포암종의 세침흡인 세포학적 소견 - 악성 림프종과의 감별을 중심으로 5예 분석 - (Fine Needle Aspiration Cytology of Metastatic Small Cell Carcinoma of Lymph Nodes - Comparison to Non-Hodgkin's Lymphoma on 5 Cases -)

  • 김연미;조혜제;고일향
    • 대한세포병리학회지
    • /
    • 제7권1호
    • /
    • pp.44-50
    • /
    • 1996
  • Small cell carcinoma of the lung is characterized by cells with finely stippled chromatin and scanty cytoplasm as well as a particularly aggressive clinical course and favorable response to the chemotherapy. Recently percutaneous fine needle aspiration (FNA) biopsy has become both widely established and highly respected for the diagnosis of lung cancer. However metastatic small cell carcinoma of lymph node should be cytologically differentiated from the small round cell tumor of particular sites, especially malignant lymphoma, because small ceil carcinoma of classic oat cell type nay simulate small cell non-Hodgkin's lymphoma. We report five cases of metastatic small cell carcinoma of in-termediate cell type diagnosed by FNA of the enlarged lymph nodes of the neck and axilla. The cytologic smears contained diffuse small neoplastic cells larger than lymphocytes with dense, pyknotic nuclei and extremely scanty cytoplasm. Apparently viable large tumor cells have vesicular nuclei with granular, sometimes very coarse chromatin. The characteristic cytologic features of small cell carcinoma as compared to malignant lymphoma were as follows.: 1) small cells with dense pyknotic nuclei are evenly distributed in the background of apparently viable larger tumor cells, admixed with mature lymphocytes and phagocytic macrophages. 2) small loose aggregates of cells with nuclear melding are indicative of small cell carcinoma rather than non-Hodgkin's lymphoma. 3) the cytoplasmic and nuclear fragments of tumor necrosis are more dominant in the smears of small cell carcinoma. 4) nuclear membrane and nucleoli are generally indistinct in small cell carcinoma due to condensation of chromatin.

  • PDF

기스트와 말토마의 보험의학적 악성도 판단 (Medical review of Insurance claims for GIST and MALToma)

  • 이신형
    • 보험의학회지
    • /
    • 제27권2호
    • /
    • pp.68-74
    • /
    • 2008
  • Medical verification of cancer diagnosis in insurance claims is a very important procedure in insurance administrations. Claims staffs are in need of medical experts' opinions about claim administration. This procedure is called medical claim review (MCR) and is composed of verification and advice. MCR verification evaluates the insured’s physical condition by medical records and compares it with product coverage. It is divided into assessment of living assurance benefit, verification of cancer, and assessment of the cause of death. Actually cancer verification of MCR is applicable to coding because the risk ratio in product development is usually coded data. There are some confusing neoplastic diseases in assessing the verification of cancer. This article reviews gastrointestinal stromal tumors (GIST) and mucosa-associated lymphoid tissue tumors (MALToma) of the stomach. The second most common group of stromal or mesenchymal neoplasms affecting the gastrointestinal tract is GIST. Nowadays there are many articles about the pathophysiology of GIST. However there are few confirmative theories except molecular cell biology of KIT mutation and some tyrosine kinase. Therefore, coding the GIST, which has previously been classified as an intermediate risk group according to NIH2001 criteria, for cancer verification of MCR is suitable for D37.1; neoplasm of uncertain or unknown behavior of digestive organs and the stomach. The gastrointestinal tract is the predominant site of extranodal non-Hodgkin's lymphomas. B-cell lymphomas of the MALT type, now called extranodal marginal zone B-cell lymphoma of MALT type in the REAL/WHO classification, are the most common primary gastric lymphomas worldwide. Its characteristics are as follows. First, it is different from traditional stomach cancers such as gastric adenocarcinoma. Second, the primary therapy of MALToma is the eradication of H. pylori by antibiotics and the remission rate is over 80%. Third, it has a different clinical course compared to traditional malignant lymphoma. Someone insisted that cancer verification is not possible for the above reasons. However, there have been findings on pathologic mechanism, and according to WHO classification, MALToma is classified into malignant B-cell lymphoma and it must be verified as malignancy in MCR.

  • PDF

Long-Term Follow-Up Clinical Courses of Cerebellar Hemangioblastoma in von Hippel-Lindau Disease : Two Case Reports and a Literature Review

  • Lee, Seung-Hwan;Park, Bong-Jin;Kim, Tae-Sung;Um, Young-Jin
    • Journal of Korean Neurosurgical Society
    • /
    • 제48권3호
    • /
    • pp.263-267
    • /
    • 2010
  • Although cerebellar hemangioblastomas are histopathologically benign, they yield a degree of malignant clinical behavior in long-term follow-up. We present two cases of long-term progression of renal cell carcinoma, which had been diagnosed as renal cysts during treatment for cerebellar hemangioblastoma. A 14-year-old male with von Hippel-Lindau disease was admitted for a cerebellar hemangioblastoma with multiple spinal hemangioblastomas and a renal cyst. After primary total resection of the cerebellar hemangioblastoma, the patient required two further surgeries after 111 and 209 months for a recurrent cerebellar hemangioblastoma. Furthermore, he underwent radical nephrectomy as his renal cyst had progressed to renal cell carcinoma 209 months after initial diagnosis. A 26-year-old male presented with multiple cerebellar hemangioblastomas associated with von Hippel-Lindau disease and accompanied by multiple spinal hemangioblastomas and multiple cystic lesions in the liver, kidney, and pancreas. He underwent primary resect'lon of the cerebellar hemangioblastoma in association with craniospinal radiation for multiple intracranial/spinal masses. Unexpectedly, a malignant glioma developed 83 months after discovery of the cerebellar hemangioblastoma. At the same time, renal cell carcinoma, which had developed from an initial renal cyst, was diagnosed, and a radical nephrectomy was performed. In the view of long term clinical course, cerebellar hemangioblastoma associated with von Hipple-Lindau disease may redevelop even after primary total resection. In addition, associated lesions such as renal cysts may also progress to malignancy after the passing of a sufficient length of time.

흉벽에 발생한 거대 악성 말초신경초종-치험 1례- (Chest Wall Giant Malignant Peripheral Nerve Sheath Tumor -One case report)

  • 박진규;김민호;조중구
    • Journal of Chest Surgery
    • /
    • 제30권7호
    • /
    • pp.729-732
    • /
    • 1997
  • 흉벽에 발생한 악성 말초신경초종은 미국에서 Mark등a(1991)이 17례를 보고하였으나 한국에서는 아직까 지 발표된 예가 없다. 악성 말초신경초종은 악성 연부 육종의 10%에서 발생되며 대개 20세에서 50세 사이에 발생한다. 악성 말 초신경초종은 주로 좌골신경, 상완신경총, 천추총과 연관되어 발생하며, 가장 흔한 발생위치는 상지와 하지 의 근위부, 체간 등이며 드물게는 두경부에도 발생한다. 악성 연부조직 육종의 치료는 저급육종(low grade sarcoma)의 경우는 종양의 절제만으로 치유 가능하나 고급육종(high grade sarcoma)의 경우는 광범위 절제가 요구된다. 저자의 경우에는 50세 남자에서 다발성 거대종괴가 좌측 흉벽에 광범위하게 있었으며 병리소견상 저급 악 성 말초신경초종으로 판명되었다. 종괴들을 절제한후 발생한 흉벽결손은 15$\times$8 cm정도 였으며 Teflon을 이용하여 재건하였다. 수술후 환자 는 큰 문제 얼이 회복되었다.

  • PDF

원발성 기관지 연관 림프조직(BALT) 림프종 3예 (Cases of the Pulmonary Malignant Lymphoma of the Bronchus-Associated Lymphoid Tissue(BALT))

  • 이상민;윤호일;최승호;황보빈;유철규;이춘택;김영환;한성구;심영수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제47권5호
    • /
    • pp.681-690
    • /
    • 1999
  • 기관지 연관 림프조직(BALT) 림프종은 폐에서 드물게 발생하는 low grade B-cell 림프종으로서, 대부분 증상이 없고 예후가 좋으며 centrocyte-like cell과 lymphoepithelial lesion이 특징적으로 관찰되어 타 장기의 림프종과는 구별되는 독특한 질병단위를 이루고 있다. 최근 면역조직화학 기법과 분자유전학 기법을 이용하여 단일클론성을 증명함으로써 BALT 림프종의 진단에 많은 도움을 받게 되었다. 저자 등은 폐생검 후 면역조직화학염색과 PCR 등의 방법으로 확진된 BALT 림프종 3예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

기관지 유암종 2례 (Two Cases Report of Bronchial Carcinoid Tumors)

  • 최교원;서정일;김성숙;정진홍;이관호;이현우;이동협;이정철;한승세
    • Journal of Yeungnam Medical Science
    • /
    • 제10권2호
    • /
    • pp.525-536
    • /
    • 1993
  • 전형 중심성 기관지 유암종과 비전형 기관지유암종을 기관지내시경하 생검 및 전산화 단층 촬영하 생검으로 확진했으며 근치적 치료로 폐절제술을 시행한 치험 2례를 문헌 고찰과 아울러 보고하는 바이다.

  • PDF

Autophagy Inhibition Promotes Gambogic Acid-induced Suppression of Growth and Apoptosis in Glioblastoma Cells

  • Luo, Guo-Xuan;Cai, Jun;Lin, Jing-Zhi;Luo, Wei-Shi;Luo, Heng-Shan;Jiang, Yu-Yang;Zhang, Yong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권12호
    • /
    • pp.6211-6216
    • /
    • 2012
  • Objective: To investigate the effects of gambogic acid (GA) on the growth of human malignant glioma cells. Methods: U251MG and U87MG human glioma cell lines were treated with GA and growth and proliferation were investigated by MTT and colony formation assays. Cell apoptosis was analyzed by annexin V FITC/PI flow cytometry, mitochondrial membrane potential assays and DAPI nuclear staining. Monodansylcadaverine (MDC) staining and GFP-LC3 localisation were used to detect autophagy. Western blotting was used to investigate the molecular changes that occurred in the course of GA treatment. Results: GA treatment significantly suppressed cell proliferation and colony formation, induced apoptosis in U251 and U87MG glioblastoma cells in a time- and dose-dependent manner. GA treatment also lead to the accumulation of monodansylcadaverine (MDC) in autophagic vacuoles, upregulated expressions of Atg5, Beclin 1 and LC3-II, and the increase of punctate fluorescent signals in glioblastoma cells pre-transfected with GFP-tagged LC3 plasmid. After the combination treatment of autophagy inhitors and GA, GA mediated growth inhibition and apoptotic cell death was further potentiated. Conclusion: Our results suggested that autophagic responses play roles as a self-protective mechanism in GA-treated glioblastoma cells, and autophagy inhibition could be a novel adjunctive strategy for enhancing chemotherapeutic effect of GA as an anti-malignant glioma agent.

Role of CD10 Immunohistochemical Expression in Predicting Aggressive Behavior of Phylloides Tumors

  • Tariq, Muhammad Usman;Haroon, Saroona;Kayani, Naila
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권8호
    • /
    • pp.3147-3152
    • /
    • 2015
  • Background: Phylloides tumors are rare breast neoplasms with a variable clinical course depending on the tumor category. Along with histologic features, the role of immunohistochemical staining has been studied in predicting their behavior. Objectives: Our aim was to evaluate the role of CD 10 immunohistochemical staining in predicting survival, recurrence and metastasis in phylloides tumor. We also evaluated correlations of other clinicopathological features with overall and disease-free survival. Materials and Methods: CD10 expression was studied in 82 phylloides tumors divided into recurrent/metastatic and non-recurrent/non-metastatic cohorts. The Chi-square test was applied to determine the significance of differences in CD10 expression between outcome cohorts. Uni and multivariate survival analyses were also performed using log-rank test and Cox regression hazard models. Results: All 3 metastatic cases, 5 out of 6 (83.3%) recurrent cases and 37out of 73 (50.7%) non-recurrent and non-metastatic cases expressed significant (2+ or 3+) staining for CD10. This expression significantly varied between outcome cohorts (p<0.03). Tumor category and histological features including mitotic count and necrosis correlated significantly with recurrence and metastasis. A significant decrease in overall and disease free survival was seen with CD10 positivity, malignant category, increased mitoses and necrosis. Neither CD10 expression nor any other clinicopathologic feature proved to be an independent prognostic indicator in multivariate analysis. Conclusions: CD10 immunohistochemical staining can be used as a predictive tool for phylloides tumor but this expression should be interpreted in conjunction with tumor category.

장측 늑막에서 발생한 저등급 섬유점액성 육종 - 1예 보고 - (Low Grade Fibromyxoid Sarcoma of the Visceral Pleura - A case report -)

  • 김연수;장선희;이성순;류지윤;박경택;장우익;김창영;조성준
    • Journal of Chest Surgery
    • /
    • 제41권1호
    • /
    • pp.141-144
    • /
    • 2008
  • 저등급 섬유점액성 육종은 드문 심연부 조직의 악성 종양이다. 비록 조직학적으로는 양성 소견을 보이지만 임상적으로는 악성 경과를 보인다. 일반적으로 하지나 체벽에서 발생하는 종양이며, 장측 늑막에서 발생된 보고는 극히 드물다. 저자들은 37세의 남자에서 장측 늑막에서 기원한 저등급 섬유점액성 육종의 증례를 보고한다. 수술 33개월째 국소재발이나 원격전이 없이 추적 관찰 중이다.